Bio-Rad Laboratories, Inc. (BIO)
Bio-Rad Laboratories, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Bio-Rad Laboratories, Inc. (BIO) is a Medical - Devices company based in US with a market capitalization of $8.5B. Revenue grew 0.7% year-over-year and the company generated $374.6M in free cash flow. This page tracks BIO's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 7.7K employees · IPO Feb 27, 1980
Valuation
Valuation & price
$247.53as of May 17, 2026· -27.1% vs 52w high
8.9
P/E ratio
Latest-FY diluted EPS
1.14
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$8.5B
Market cap
0.7%
Revenue growth (YoY)
52.0%
Gross margin
$374.6M
Free cash flow (USD)
-$11.7M
Net debt
Net cash position
-3.4%
Share dilution
3/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
1
Insider sells · 90 days
Earnings
Last report: 10-Q filed Apr 30, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is Bio-Rad Laboratories, Inc.'s market cap?
Bio-Rad Laboratories, Inc. (BIO) has a market capitalization of $8.5B.
What is BIO's P/E ratio?
BIO trades at a price-to-earnings ratio of 8.9, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
What is BIO's price-to-book (P/B) ratio?
BIO trades at 1.14 times book value per share.
Are insiders buying BIO stock?
SEC Form 4 filings show no open-market insider buys at Bio-Rad Laboratories, Inc. in the last 90 days (1 sell).
Same arena
Related companies in Medical - Devices
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.